SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-18-002717
Filing Date
2018-03-16
Accepted
2018-03-16 17:14:20
Documents
1
Period of Report
2017-11-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 1481
  Complete submission text file 0001654954-18-002717.txt   3134
Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602
Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1825 K STREET SUITE 510 WASHINGTON DC 20006
Business Address
Cross Shawn (Reporting) CIK: 0001734779 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-08092 | Film No.: 18696606